Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

Ina Kötter; Manfred Zierhut; Anja Eckstein; Reinhard Vonthein; Thomas Ness; Ilhan Günaydin; Bodo Grimbacher; Sabine Blaschke; Hans Hartmut Peter; Lothar Kanz; Nicole Stübiger

Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

Ina Kötter^*, Manfred Zierhut, Anja Eckstein, Reinhard Vonthein, Thomas Ness, Ilhan Günaydin, Bodo Grimbacher, Sabine Blaschke, Hans Hartmut Peter, Lothar Kanz, Nicole Stübiger

^*Corresponding author for this work

Institute of Medical Biometry and Statistic

University of Tubingen

22 Citations (Scopus)

Original language	English
Journal	Advances in Experimental Medicine and Biology
Volume	528
Pages (from-to)	521-523
Number of pages	3
ISSN	0065-2598
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{52574965fb964d4d95e2e289da7c61de,

title = "Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Beh{\c c}et's disease with sight-threatening retinal vasculitis.",

author = "Ina K{\"o}tter and Manfred Zierhut and Anja Eckstein and Reinhard Vonthein and Thomas Ness and Ilhan G{\"u}naydin and Bodo Grimbacher and Sabine Blaschke and Peter, {Hans Hartmut} and Lothar Kanz and Nicole St{\"u}biger",

year = "2003",

language = "English",

volume = "528",

pages = "521--523",

journal = "Advances in Experimental Medicine and Biology",

issn = "0065-2598",

}

TY - JOUR

T1 - Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

AU - Kötter, Ina

AU - Zierhut, Manfred

AU - Eckstein, Anja

AU - Vonthein, Reinhard

AU - Ness, Thomas

AU - Günaydin, Ilhan

AU - Grimbacher, Bodo

AU - Blaschke, Sabine

AU - Peter, Hans Hartmut

AU - Kanz, Lothar

AU - Stübiger, Nicole

PY - 2003

Y1 - 2003

UR - http://www.scopus.com/inward/record.url?scp=17144438663&partnerID=8YFLogxK

M3 - Journal articles

C2 - 12918755

AN - SCOPUS:17144438663

SN - 0065-2598

VL - 528

SP - 521

EP - 523

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

ER -

Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

UN SDGs

Other files and links

Cite this